- Intraocular Pressure: Intravitreal Preservative-free Triamcinolone Injection in Diabetic Macular Edema and Branch Retinal Vein Occlusion
-
Lee CH, Seo YS
- KMID: 2470739
- J Korean Ophthalmol Soc.
- 2020 Feb;61(2):167-174.
- doi: 10.3341/jkos.2020.61.2.167
PURPOSE: To compare the intraocular pressure (IOP) in diabetic macular edema (DME) patients and macular edema associated with branch retinal vein occlusion (BRVO) patients after intravitreal preservative-free Triamcinolone injection. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients
-
Kim SY, Yoon MH, Chin HS
- KMID: 2469282
- Korean J Ophthalmol.
- 2020 Feb;34(1):11-18.
- doi: 10.3341/kjo.2019.0081
PURPOSE: To investigate the effect of intravitreal anti-vascular endothelial growth factor (VEGF) injections on ganglion cell-inner plexiform layer (GCIPL) thickness in patients with age-related macular degeneration (AMD). METHODS: This retrospective study... -
- CITED
-
- Close
- SHARE
-
- Close
- Retinal Toxicity Following the Injection Ganciclovir into Silicone Oil-filled Eye to Treat Acute Retinal Necrosis
-
Jo YJ, Choi SK, Park SH, Lee JJ, Lee JE, Park SW
- KMID: 2468484
- J Korean Ophthalmol Soc.
- 2020 Jan;61(1):111-115.
- doi: 10.3341/jkos.2020.61.1.111
PURPOSE: To report a case of retinal toxicity after an intravitreal ganciclovir injection to treat acute retinal necrosis in an eye filled with silicone oil. CASE SUMMARY: A 56-year-old male presented... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Intravitreal Dexamethasone Implant for Diabetic Macular Edema According to Previous Responses to Bevacizumab
-
Kim D, Park DG, Ryu G, Sagong M
- KMID: 2468476
- J Korean Ophthalmol Soc.
- 2020 Jan;61(1):51-58.
- doi: 10.3341/jkos.2020.61.1.51
PURPOSE: To compare the efficacy of intravitreal dexamethasone implants according to previous response to bevacizumab treatment in patients with diabetic macular edema (DME). METHODS: Forty-nine eyes of 49 patients who received... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparision of Hyperreflective Foci after Treatment of Diabetic Macular Edema Patients between Intravitreal Injections
-
Kim M, Park K, Yi MY, Lee SJ
- KMID: 2468475
- J Korean Ophthalmol Soc.
- 2020 Jan;61(1):41-50.
- doi: 10.3341/jkos.2020.61.1.41
PURPOSE: To compare the outcomes in patients with diabetic macular edema (DME) treated with intravitreal dexamethasone implants and intravitreal bevacizumab injections. METHODS: A retrospective cohort study was designed using 66 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary to Optic Nerve Head Drusen
-
Park KH
- KMID: 2466198
- J Korean Ophthalmol Soc.
- 2019 Dec;60(12):1369-1373.
- doi: 10.3341/jkos.2019.60.12.1369
PURPOSE: To describe a patient with optic nerve head drusen who showed improved retinal hemorrhage and visual acuity following intravitreal anti-vascular endothelial growth factor (bevacizumab) injection. CASE SUMMARY: A 53-year-old woman... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Short-term Effects of Intravitreal Injection of Three Modalities on Central Retinal Vein Occlusion
-
Jeong JS, Lee DW, Kim BS, Yoo WS, Chung IY, Park JM
- KMID: 2463358
- J Korean Ophthalmol Soc.
- 2019 Nov;60(11):1072-1079.
- doi: 10.3341/jkos.2019.60.11.1072
PURPOSE: To report the short-term effects of intravitreal bevacizumab alone, low-dose bevacizumab combined with low-dose triamcinolone injection, and intravitreal dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) injection in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
-
Chung YR, Ha KH, Kim HC, Park SJ, Lee K, Kim DJ
- KMID: 2460957
- Diabetes Metab J.
- 2019 Oct;43(5):640-648.
- doi: 10.4093/dmj.2018.0137
BACKGROUND: To investigate the effects of dipeptidyl peptidase-4 inhibitor (DPP4i) as add-on medications to metformin on progression of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus, compared with... -
- CITED
-
- Close
- SHARE
-
- Close
- Fulminant Toxoplasmic Chorioretinitis Following Intravitreal Dexamethasone Implantation
-
Jeong A, Park DG, Sagong M
- KMID: 2459136
- J Korean Ophthalmol Soc.
- 2019 Sep;60(9):896-900.
- doi: 10.3341/jkos.2019.60.9.896
PURPOSE: To report a case of fulminant toxoplasmic chorioretinitis following intravitreal dexamethasone implantation monotherapy in a stabilized toxoplasmic chorioretinitis patient with initial treatment. CASE SUMMARY: A 60-year-old healthy female presented with... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Prognosis of Endogenous Endophthalmitis in Western Gyeongsangnam-do
-
Jeong JS, Shin MH, Seo JS, Yoo WS, Park JM, Chung IY
- KMID: 2459129
- J Korean Ophthalmol Soc.
- 2019 Sep;60(9):851-858.
- doi: 10.3341/jkos.2019.60.9.851
PURPOSE: To investigate the clinical features and prognosis associated with endogenous endophthalmitis (EE) in western Gyeongsangnam-do over an 11-year period. METHODS: This study was a retrospective review of the medical records... -
- CITED
-
- Close
- SHARE
-
- Close
- Choroidal Neovascularization in a Patient with Best Disease
-
Jung JU, Kim YM, Kang YK, Park DH, Shin JP
- KMID: 2455466
- J Korean Ophthalmol Soc.
- 2019 Aug;60(8):808-815.
- doi: 10.3341/jkos.2019.60.8.808
PURPOSE: To report a case of choroidal neovascularization in a Best disease patient treated with intravitreal bevacizumab injection and followed up with optical coherence tomography angiography (OCTA). CASE SUMMARY: A 20-year-old... -
- CITED
-
- Close
- SHARE
-
- Close
- Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration
-
Cho S, Shin SJ, Suh JK, Tchoe H, Kang MJ, Yang J, Jee D
- KMID: 2455458
- J Korean Ophthalmol Soc.
- 2019 Aug;60(8):758-764.
- doi: 10.3341/jkos.2019.60.8.758
PURPOSE: To evaluate the current use of intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) in patients with age-related macular degeneration (AMD). METHODS: We analyzed the number and medical costs of... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Injection of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration: a Systematic Review
-
Kang MJ, Shin SJ, Suh JK, Cho S, Tchoe H, Yang J, Jee D
- KMID: 2455457
- J Korean Ophthalmol Soc.
- 2019 Aug;60(8):748-757.
- doi: 10.3341/jkos.2019.60.8.748
PURPOSE: To compare the efficacy and safety of intravitreal injections of bevacizumab, ranibizumab, and aflibercept for the treatment of new patients with age-related macular degeneration (AMD). METHODS: We conducted an update... -
- CITED
-
- Close
- SHARE
-
- Close
- Subfoveal Choroidal Thickness Changes after Intravitreal Bevacizumab in Macular Edema Secondary to Retinal Vein Occlusion
-
Lee JY, Song SJ, Lee MY, Bae JH
- KMID: 2455456
- J Korean Ophthalmol Soc.
- 2019 Aug;60(8):740-747.
- doi: 10.3341/jkos.2019.60.8.740
PURPOSE: To determine changes in subfoveal choroidal thickness (SCT) after intravitreal injection of bevacizumab in eyes with macular edema secondary to retinal vein occlusion (RVO). METHODS: Forty-four patients treated with intravitreal... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data
-
Cho S, Shin SJ, Suh JK, Tchoe H, Yang J, Kang MJ, Jee D
- KMID: 2453017
- J Korean Ophthalmol Soc.
- 2019 Jul;60(7):661-666.
- doi: 10.3341/jkos.2019.60.7.661
PURPOSE: To evaluate the current use of intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) in patients with diabetic retinopathy. METHODS: We determined the current number of diabetic retinopathy patients and... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary Intraocular T-cell Lymphoma
-
Shin YI, Kim JM, Lee JJ, Kim JY, Kim J, Jo YJ
- KMID: 2449714
- J Korean Ophthalmol Soc.
- 2019 Jun;60(6):594-599.
- doi: 10.3341/jkos.2019.60.6.594
PURPOSE: Intraocular lymphoma can be divided into primary and secondary usually involving B-cell lymphoma. Intraocular T-cell lymphoma is mostly secondary lymphoma while primary intraocular T-cell lymphoma is extremely rare. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Precipitation of Vancomycin and Ceftazidime on Intravitreal Injection in Endophthalmitis Patients
-
Noh GM, Nam KY, Lee SU, Lee SJ
- KMID: 2448871
- Korean J Ophthalmol.
- 2019 Jun;33(3):296-297.
- doi: 10.3341/kjo.2018.0080
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
-
Kang HG, Kim TY, Han J, Han SH
- KMID: 2448867
- Korean J Ophthalmol.
- 2019 Jun;33(3):272-278.
- doi: 10.3341/kjo.2019.0011
PURPOSE: To compare long-term refractive outcomes associated with intravitreal anti-vascular endothelial growth factor (VEGF) versus laser photocoagulation treatment for retinopathy of prematurity (ROP). METHODS: A total of 52 eyes from 27... -
- CITED
-
- Close
- SHARE
-
- Close
- Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review
-
Park KH, Kim YY, Jo YJ, Oh J, Lee JE, Lee JE, Park DH, Kang SW, Lee WK, Kim HK, Adena M, Tan J, Kim SD
- KMID: 2443206
- J Korean Med Sci.
- 2019 Apr;34(15):e118.
- doi: 10.3346/jkms.2019.34.e118
BACKGROUND: Limited data exist on real-world treatment patterns for diabetic macular edema (DME) in Korea. In this study, we investigated DME treatment patterns from 2009 to 2014 and the impact... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept
-
Moon TK, Ha JY, Sung MS, Park SW
- KMID: 2443153
- J Korean Ophthalmol Soc.
- 2019 Apr;60(4):362-368.
- doi: 10.3341/jkos.2019.60.4.362
PURPOSE: To evaluate long-term intraocular pressure (IOP) and risk of IOP elevation after intravitreal injection of ranibizumab or aflibercept in patients with age-related macular degeneration (AMD). METHODS: From January 2013 to... -
- CITED
-
- Close
- SHARE
-
- Close
